CTLA4 and neoplasm: However, importantly, within the CD4-NFAT5-KO transgenic mice, compared to no treatment (Figure 6F–H), treatment with anti-CTLA4 (Figure 7A–C) significantly reduced the tumor progression kinetics in all three salt modified diet cohorts.